ALNY vs BRBS · P/E 76, rev $1.29B vs rev $58.2M
Alnylam Pharmaceuticals Inc (ALNY) versus Blue Ridge Bankshares Inc (BRBS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Blue Ridge Bankshares Inc (BRBS) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported BRBS revenue for 2026-06-30 was $58.2M. Net income was -$459.0K. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. BRBS currently screens at market cap $328.2M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. BRBS currently screens at market cap $328.2M.
Not investment advice. Open the ALNY and BRBS stock pages for the full models.
Not investment advice.